{"name":"AQILION AB","slug":"aqilion-ab","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"AQ280 Capsule","genericName":"AQ280 Capsule","slug":"aq280-capsule","indication":"Other","status":"phase_1"},{"name":"AQ280 Tablet for Oral Suspension","genericName":"AQ280 Tablet for Oral Suspension","slug":"aq280-tablet-for-oral-suspension","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"AQ280 Capsule","genericName":"AQ280 Capsule","slug":"aq280-capsule","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"AQ280 Tablet for Oral Suspension","genericName":"AQ280 Tablet for Oral Suspension","slug":"aq280-tablet-for-oral-suspension","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPY1c0X0c5SzJ0TDZfMFZHc0lIVkpJaXg0U2NmY2hGVDFCdkx2azNhNjVvOXA1elVEdElOSHFDWlZZVERJZjhsNDZlQ2ZGMGpTRWVVSVFsN2NwdHpobjBqNFBuc3d3c1BLQlcyX1hNWlZuQmNXWkx5MHFYWXVmNUhQd3Z4eVZDdWpOdy1GeXJMNUJGeUl4Rk1tSlpaMkJFQkxy?oc=5","date":"2023-02-16","type":"deal","source":"BioWorld News","summary":"Merck signs on to Aqilion’s autoimmune project in €960M deal - BioWorld News","headline":"Merck signs on to Aqilion’s autoimmune project in €960M deal","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}